Company / Cost of Revenue
Beta Bionics, Inc. Cost of Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$44.7M
FY2025
5-year range
$5.7M / $44.7M
FY2023-FY2025
Trend
+52.9%
vs FY2024
Sector context
#105 of 113
Health Care
What the data says
Among 113 Health Care companies, Beta Bionics, Inc. is in the top 7% for cost of revenue. Increased from $6M to $45M over the past 2 years.
Based on SEC 10-K filings.
$45M in FY2025.
Increased from $6M to $45M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 113This company $44.7M Sector average $11.3B
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, cost of revenue increased 52.9% year-over-year.
- Ranks #105 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.7M | +52.9% |
| FY2024 | $29.2M | +414.1% |
| FY2023 | $5.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026